Urological area
Urothelium, bladder and prostate: the in vitro models used to document the effect of an ingredient or a supplement on the urinary tract and prostate health.
Physiological areas
GastrointestinalMetabolism and cardiovascular systemDermatologicalNeurologicalOphthalmicMusculoskeletalRespiratoryOralUrologicalVaginalImmune systemWhat you can demonstrate here
Recurrent cystitis, prostate wellbeing, urinary comfort: these are needs for which the consumer looks for non-pharmacological answers, and where a figure on biofilm or on urothelial cells sets a product apart from the rest of the shelf. Here we measure both the action on pathogens and the effect on tissues.
The models we use
What we measure
- Antimicrobial activity with MIC determination
- Antibiofilm activity, preventive and curative
- Antimicrobial activity over time
- Urinary microbiota: growth or inhibition on a panel of uropathogenic and commensal strains, to check that the ingredient contains pathogens without depleting the protective flora
- Anti-inflammatory activity on urothelial cells
- Antioxidant activity on urothelial cells
- Wound healing and regenerative action on the urothelium
- Anti-inflammatory activity on prostate cells
- Antioxidant activity on prostate cells
- Anti-androgenic action on prostate cells
- Anti-proliferative action on prostate cells
- Total antioxidant capacity (TEAC)
- Modulation of cortisol release
What is measured in this area
Urothelium, bladder and prostate: the endpoints that document the effect of an ingredient on the urinary tract and prostate health.
- Bacterial adhesion — the ability of pathogens to attach to the urothelium
- Biofilm formation — biofilm development and structure under the conditions tested
- Urothelial integrity — the tightness of the barrier lining the urinary tract
- Inflammatory response — cytokines released by urothelial cells
- Prostate cells — proliferation and viability under the conditions tested
- Hormonal enzymes — activity on the enzymes involved in hormone metabolism
- Oxidative stress — reactive species and defences in urogenital tissue
- Hormonal response — markers of the cellular response to hormonal stimuli
What you receive
- A report with model, protocol, controls and raw data
- Results per replicate, with mean and spread declared
- Quantification of adhesion and biofilm, not a visual estimate
- Separate outcomes for the urinary and prostatic components
- A readable comparison between the conditions tested, usable in a technical dossier or in a conversation with a downstream customer
Who it is for, and where to start
- You are choosing between raw materials and need a measured criterion: ingredient validation and valorisation
- You have a finished product and want to know how much stays active in the formulation: supplement valorisation
- You need an ingredient that does not exist yet for this function: development of new ingredients
